Associated Papers
The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
Liu W et al.
Molecular Oncology, 2024
37727135 (PubMed )
Supplement: MOL2-18-939-s001.pdf
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.
Monti P et al.
Scientific Reports, 2020
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
27683183 (PubMed )
Supplement: 10780432ccr161679-sup-168576_1_supp_3636667_wcc1ns.docx
Identifying the determinants of response to MDM2 inhibition.
Saiki AY et al.
Oncotarget, 2015
25730903 (PubMed )
Supplement: oncotarget-06-7701-s002.xls › Proliferation
Select a paper to view details